EXHIBIT 10.27.1
AMENDMENT
This AMENDMENT is to the License Agreement dated as of November 6, 1997
(hereinafter, the Agreement) between U. S. Bioscience, Inc. (hereinafter,
Licensor) and Scherico, Ltd. (hereinafter, Licensee), and is effective as of
January 13, 1998.
Any terms used herein which are defined in the Agreement shall have the meanings
ascribed to them in the Agreement.
If there is a conflict between a provision of the Agreement and this Amendment,
then this Amendment shall prevail.
The parties hereto agree to amend the Agreement as follows:
1. A new Section 2.8 is hereby added to the Agreement as follows:
2.8 Licensee shall have the right to expand the Territory to
include the countries of Saudi Arabia, Jordan and United Arab Emirates
upon the lapse of preexisting rights to commercialize the Products
that have been granted by Licensor to Al-Haya Medical Company, Al-
Faiasel Drugstore and Pharmatrade (Abu Dhabi), respectively. Licensor
shall notify Licensee if the right to commercialize the Products in
any such country becomes available, and Licensee shall thereafter have
thirty (30) days in which to elect to include such country within the
Territory under the terms of this Agreement.
2. Annex II is hereby amended by the addition of the following countries to
the Territory:
Kuwait
Qatar
Oman
Bahrain
Lebanon
Syria
3. For the countries listed in paragraph 2 above, the notification period
provided in Section 2.7 of the Agreement is hereby waived, and it is agreed
that the Licensee shall immediately file applications for the Trademark(s)
pursuant to Section 2.7 of the Agreement.
This Amendment, to the extent set forth herein, amends, modifies and supplements
the Agreement. Except as expressly modified herein, all of the terms and
provisions of the Agreement remain in full force and effect and cannot be
amended, modified or changed in any way whatsoever except by a written
instrument duly executed by the parties hereto.
IN WITNESS WHEREOF, the parties have caused this Amendment to be executed by
their authorized representatives on the dates indicated below.
U.S. BIOSCIENCE, INC. SCHERICO, LTD.
By: /s/ Xxxxxxx Xxxxxxx By: /s/ Xxxx-Xxxx Xxxxxx
------------------------------------ ---------------------------------
Title: VP Licensing & Bus. Development Title: Director
-------------------------------- ------------------------------
Date: January 13, 1998 Date: January 29, 1998
-------------------------------- -------------------------------
2
